8-KEarnings & ResultsLeadership ChangesExhibits & Filings

GE HealthCare Technologies Inc. 8-K Report, Financial Results (Jul 23, 2026)

Filed July 23, 2026For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) has filed an 8-K report disclosing preliminary unaudited financial results for the second quarter of 2026, which were also announced via a press release furnished as Exhibit 99. While specific figures for revenue and EPS are not detailed within the 8-K text itself, the furnishing of this preliminary data suggests the company is providing early guidance to the market. Investors should closely review the accompanying press release for the actual Q2 2026 performance metrics. Furthermore, the filing announces a significant leadership change: Chief Financial Officer James K. (Jay) Saccaro will be resigning on August 14, 2026, to pursue opportunities outside the medical technology sector. George Newcomb, currently Controller and Chief Accounting Officer, has been appointed interim CFO, effective August 14, 2026. Mr. Newcomb brings extensive finance experience from GE and GE Capital. The company has initiated a search for a permanent CFO. Investors should monitor the transition and the search process for a new CFO.

Key Highlights

  • 1GE HealthCare released preliminary unaudited Q2 2026 revenue and EPS results via press release.
  • 2Specific Q2 2026 financial figures are not detailed in the 8-K text but are available in the furnished press release (Exhibit 99).
  • 3CFO James K. (Jay) Saccaro is resigning effective August 14, 2026, to take a role outside the medical technology industry.
  • 4George Newcomb, Controller and Chief Accounting Officer, has been appointed interim CFO, effective August 14, 2026.
  • 5Mr. Newcomb's compensation will not change with his interim CFO role.
  • 6GE HealthCare has begun searching for a permanent CFO successor.
  • 7The filing includes standard disclaimers regarding the non-filed status of the furnished information under Section 18 of the Exchange Act.

Frequently Asked Questions

The preliminary unaudited Q2 2026 revenue and EPS results were announced in a press release furnished as Exhibit 99 to this 8-K filing. Investors should refer to Exhibit 99 for these specific financial figures.

Jay Saccaro's last day as CFO will be August 14, 2026. George Newcomb, currently the Controller and Chief Accounting Officer, has been appointed interim CFO and will assume the role effective August 14, 2026. A search for a permanent CFO is underway.

George Newcomb has a long history in finance, previously serving as Controller for GE's healthcare business and holding various finance leadership roles at GE Capital. He was named Controller and Chief Accounting Officer of GE HealthCare in January 2023. He has no reportable transactions with GE HealthCare under Item 404(a) of Regulation S-K, and his compensation will remain unchanged in his interim CFO role.

No, the information furnished in the press release (Exhibit 99) under Item 2.02 is generally not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section, unless expressly incorporated by reference into another SEC filing.